MedTrace Logo

Refractive Surgery and Optive Compatibility Study

NCT00469157 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2008-04-17

No results posted yet for this study

Summary

To assess the compatibility of Optive with refractive surgery (PRK and LASIK) post-operatively.

Conditions

  • Dry Eye Syndromes

Interventions

DRUG

Optive

Optive 30ml- (in the eye) Instill one in each eye twice daily starting one week after surgery

Sponsors & Collaborators

  • Innovative Medical

    lead INDUSTRY

Principal Investigators

  • Loren Rude, OD · TLC

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2008-04-30
Completion
2008-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00469157 on ClinicalTrials.gov